A rat model of Parkinson's disease induced by Japanese encephalitis virus

Journal of NeuroVirology

Volumn 3, Issue 2, 1997, Pages 141-147

  Ogata, Akihiko ^a   Tashiro, Kunio ^a   Nukuzuma, Souichi ^a   Nagashima, Kazuo ^a   Hall, William W ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Brain; Japanese encephalitis virus; Parkinsonism; Substantia nigra; Viral tropism

Indexed keywords

ANTIGEN; LEVODOPA; OXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRADYKINESIA; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; GENOME; GLIOSIS; IMMUNOHISTOCHEMISTRY; JAPANESE ENCEPHALITIS VIRUS; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; VIRUS INFECTION;

EID: 0030894072     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289709015803     Document Type: Article

References (39)

1. Adams JD, Odunze IN (1991). Oxigen free radicals and Parkinson's disease. Free Radical Biol Med 10: 161-169.
2. Alves RSC, Barbosa ER, Scaff M (1992). Postvaccinial parkinsonism. Movement Disorders 7: 178-180.
3. Appel SH, Le W-D, Tajti J, Haverkamp LJ, Engelhardt JI (1992). Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs. Ann Neurol 32: 494-501.
4. Ballard PA, Tetrud JW, Langston JW (1985). Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35: 949-956.
5. Bojinov S (1971). Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci 12: 383-415.
6. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983). A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546-4550.
7. Calne DB, Langston JW (1983). Aetiology of Parkinson's disease. Lancet ii: 1457-1459.
8. Chiueh CC, Markey SP, Burns RS et al (1983). N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a parkinsonian syndrome causing agent in man and monkey, produces different effects in guinea pig and rat. Pharmacologist 25: 131.
9. Cohen G (1986). Monoamine oxidase, hydrogen peroxidase and Parkinson's disease. Adv Neurol 45: 119-125.
10. Dexter DT, Wells FR, Lees AJ, et al (1989). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830-1836.
11. Dickerson RB, Newton JR, Hansen JE (1952). Diagnosis and immediate prognosis of Japanese B encephalitis. Am J Med 12: 277-288.
12. Duvoisin RC, Yahr MD (1965). Encephalitis and parkinsonism. Arch Neurol 12: 227-239.
13. Fishman PS, Gass JS, Swoveland PT, Lavi E, Highkin MK, Weiss SR (1985). Infection of the basal ganglia by a murine coronavirus. Science 229: 877-879.
14. Geddes JF, Hughes AJ, Lees AJ, Daniel SE (1993). Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 116: 281-302.
15. Gibb WRG, Lees AJ (1987). The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome. Acta Neuropathol (Berl) 73: 195-201.
16. Goto A (1962). Follow-up study of Japanese B encephalitis. Psychiat Neurol Jpn (Tokyo) 64: 236-266.
17. Heikkila RE, Hess A, Duvoisin RC (1984). Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224: 1451-1453.
18. Hsu SM, Raine L, Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580.
19. Hudson AJ, Rice GPA (1990). Similarities of Guamanian ALS/PD to post-encephalitic parkinsonism/ALS: possible viral cause. Can J Neurol Sci 17: 427-433.
20. Kelly PH, Seviour PW, Iversen SD (1975). Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Research 94: 507-522.
21. Kimura-Kuroda J, Ichikawa M, Ogata A, Nagashima K, Yasui K (1993). Specific tropism of Japanese encephalitis virus for developing neurons in primary rat brain culture. Arch Virol 130: 477-484.
22. Kristensson K (1992). Potential role of viruses in neurodegeneration. Molecular and Chemical Neuropathology 10: 45-58.
23. Langston JW, Ballard P, Tetrud JW, Irwin I (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980.
24. Langston JW (1989). Current theories on the cause of Parkinson's disease. J Neu Neurosurg Psychiatry 52: 13-17.
25. McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988). Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24: 574-576.
26. Morita K, Tanaka M, Igarashi A (1991). Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol 29: 2107-2110.
27. Nagatsu T, Yoshida M (1988). An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primate with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87: 178-182.
28. Ogata A, Nagashima K, Hall WW, Ichikawa M, Kimura-Kuroda J, Yasui K (1991). Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 65: 880-886.
29. Ogawa N, Hirose Y, Ohara T, et al (1985). A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 50: 435-441.
30. Richter RW, Shimojyo S (1961). Neurologic sequelae of Japanese B encephalitis. Neurology 11: 553-559.
31. Riederer P, Sotic E, Rausch WD, et al (1989). Transition metals ferritin, glutathione and ascorbic acid in Parkinsonian brain. J Neurochem 52: 515-520.
32. Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F (1993). Japanese encephalitis and parkinsonism. J Neurol 240: 59-60.
33. Sumiyoshi H, Mori C, Fuke I, et al (1987). Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497-510.
34. Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H (1995). The substania nigra is a major target for neurovirulent influenza A virus. J Exp Med 181: 2161-2169.
35. Vingerhoets FJG, Snow BJ, Tetrud JW, Langston JW, Schulzer M, Calne DB (1994). Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 36: 765-770.
36. von Economo C (1917). Encephalitis lethargica. Wien klin Wschr 30: 581-585.
37. Walters JH (1960). Post-encephalitic parkinson syndrome after meningoencephalitis due to coxsackie virus group B, type 2. New Eng J Med 263: 744-747.
38. Yahr MD (1978). Encephalitis lethargica (Von Economo's disease, epidemic encephalitis). In: Handbook of clinical neurology, Vinken PJ, Bruyn GW, (eds.) volume 34. Amsterdam: North-Holland, pp 451-457.
39. Yoshida M, Miwa T, Nagatsu T (1990). Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes. Neurosci Lett 119: 109-113.